Olink Reveal - Simultaneous analysis of over 1000 proteins.
Next-generation proteomics expanding with NGS - Efficient analysis of approximately 1,000 proteins.
Olink Reveal is a next-generation proteomics analysis solution that utilizes NGS. It can be operated with various existing next-generation sequencers (NGS) and streamlines drug discovery research and cohort studies. The protein list included can be downloaded from the related link site or you can contact us for more information. ■Features - Simultaneous measurement of approximately 1,000 proteins from just 4 µL of serum or plasma - "Mid-Plex" panel with an excellent balance of cost and information volume - Carefully selected markers of high clinical importance, including inflammation, cancer, and neurology - Supports multi-sample and large-scale studies based on NGS ■Benefits - Ideal for screening applications where Explore HT may be excessive - Efficient data acquisition suitable for hypothesis validation phases - Maintains consistency of data with other Olink panels through PEA technology ■Applications - Biomarker discovery and validation - Cohort studies and multi-omics analysis - Drug discovery and translational research
Inquire About This Product
basic information
You can simultaneously detect 1,034 types of proteins from a 4 µL sample. It takes just under two days to acquire the data, with only 2.5 hours of hands-on time. The cost is also reasonable. The list of proteins included can be downloaded from the related link site. For further inquiries, please contact Japan@olink.com.
Price information
Please contact us at Japan@olink.com.
Delivery Time
Applications/Examples of results
Biobanks focused on regional populations can help understand dynamics influenced by lifestyle and genetic factors, and obtain relevant biological insights. Examples: - Utilizing the Bialystok PLUS cohort (1), randomly sampled from residents of Bialystok, Poland, we identified proteins associated with type 2 diabetes (T2D) and prediabetes. - At the Karolinska Institute, we analyzed plasma samples from chronic lymphocytic leukemia (CLL) patients treated with Bruton's tyrosine kinase inhibitors (BTKi) to gain practical insights regarding treatment responses. For research use only. Not for diagnostic purposes.
Detailed information
-
Differentiation of the Olink platform
catalog（2）
Download All Catalogs
Company information
Thermo Fisher Scientific K.K., the Japanese subsidiary of Thermo Fisher Scientific Incorporated, is a sales company for comprehensive system analysis instruments, bio-related equipment, and research reagents. In Japan, it has bases in Yokohama, Tokyo, Osaka, Fukuoka, and Nagoya, handling various analytical instruments including mass spectrometers, various bio-related equipment, measuring instruments, medical devices, lab software, and research reagents.